跳转至内容
Merck

10005

Sigma-Aldrich

氯化氨基汞

≥95.0%, powder

别名:

氨基氯化汞(II)

登录查看公司和协议定价


About This Item

线性分子式:
(HgNH2)Cl
CAS号:
分子量:
252.07
EC號碼:
MDL號碼:
分類程式碼代碼:
12161600
PubChem物質ID:
NACRES:
NA.22
产品10005监管中,请联系销售询价或购买 联系技术服务部门

品質等級

化驗

≥95.0%

形狀

powder

反應適用性

core: mercury
reagent type: catalyst

SMILES 字串

N[Hg]Cl

InChI

1S/ClH.Hg.H2N/h1H;;1H2/q;+2;-1/p-1

InChI 密鑰

WRWRKDRWMURIBI-UHFFFAOYSA-M

訊號詞

Danger

危險分類

Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT RE 2

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Waranya Boonchai et al.
Contact dermatitis, 65(6), 311-316 (2011-11-15)
Contact allergy to cosmetic ingredients is common. However, there are no recent comprehensive studies on contact allergy to cosmetic ingredients in Asia. To identify positive patch test reactions in patients tested at Siriraj Hospital, Bangkok, Thailand to allergens present in
C C Sun
Contact dermatitis, 17(5), 306-309 (1987-11-01)
A total of 507 (M 121, F 386) cases of facial dermatitis were investigated, of whom 308 (M 49, F 259) had eczema confined to the face. The prevalence of positive patch tests was 45% (229/507). Among all the patients
D Deleu et al.
Journal of toxicology. Clinical toxicology, 36(3), 233-237 (1998-07-10)
Despite their potentially disastrous side effects, topical mercury salts can still be found as ingredients in some over-the-counter preparations or local remedies. Peripheral polyneuropathy as a result of chronic ammoniated mercury poisoning was studied and followed over 2 years. A
Mercury as a health hazard.
E S Mucklow
Archives of disease in childhood, 63(11), 1416-1417 (1988-11-01)
James E Melnyk et al.
Bioorganic & medicinal chemistry, 28(20), 115712-115712 (2020-10-18)
Alternative splicing of the androgen receptor (AR) is frequently observed in castration resistant prostate cancer (CRPC). One AR isoform, the AR-V7 splice variant, is a constitutively active transcription factor which lacks a ligand binding domain and is therefore undruggable. AR-V7

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门